Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications

2006 ◽  
Vol 77 (4) ◽  
pp. 327-333 ◽  
Author(s):  
Naseema Gangat ◽  
Alexandra P. Wolanskyj ◽  
Ayalew Tefferi
2020 ◽  
Vol 99 (4) ◽  
pp. 791-798 ◽  
Author(s):  
Alberto Alvarez-Larrán ◽  
◽  
Arturo Pereira ◽  
Marta Magaz ◽  
Juan Carlos Hernández-Boluda ◽  
...  

Hematology ◽  
2016 ◽  
Vol 2016 (1) ◽  
pp. 552-560 ◽  
Author(s):  
Jamile M. Shammo ◽  
Brady L. Stein

The last decade has witnessed tremendous scientific advances, ushered in by the JAK2 V617F discovery, contributing to enhanced diagnostic capability and understanding of the biology of myeloproliferative neoplasms (MPNs). Discovery of the calreticulin mutations filled a diagnostic gap; more recent work sheds light on its contribution to disease pathogenesis, and prognosis. Recent studies have also identified novel JAK2 and MPL mutations in patients with essential thrombocythemia and myelofibrosis (MF). Especially in MF, the driver mutational profile has prognostic implications, with additive contributions from the acquisition of additional somatic mutations. The hope is that sophisticated molecular profiling will not only aid in prognostication, but also guide selection of therapy for patients with MPNs.


2005 ◽  
Vol 329 (3) ◽  
pp. 139-140 ◽  
Author(s):  
Jason Eli Tache ◽  
Sramila Aithal ◽  
Allan Novetsky ◽  
Yi-Wu Huang ◽  
Norman Saffra ◽  
...  

1993 ◽  
Vol 125 (2) ◽  
pp. 410-422 ◽  
Author(s):  
Antonello Gayazzi ◽  
Renata De Maria ◽  
Giuliano Renosto ◽  
Agnese Moro ◽  
Massimo Borgia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document